This free webinar provides an overview of the comprehensive process to establish pathway-specific and fact-based evidence requirements for medical technologies to meet the requirements of reimbursement, funding and HTA authorities
Understanding evidence requirements of reimbursement/HTA authorities is critical for the success of medical technologies.
Typically, evidence generation is driven by the need, determined by the outside clinical experts and internal regulatory and clinical specialists. Market access perspective is often not taken into account.
A high-level understanding of evidence requirements is common. For example, for a novel treatment method, at least one RCT and some supportive studies of other designs (e.g. case series) are needed. However, there are many situations when this general wisdom is not applicable. It could be the case of diagnostic technology (e.g. endoscopy or other imaging), in-vitro diagnostic test, or technology, for which RCT design is not feasible. Also, there are many other relevant nuanced questions, like selection of the target population, comparator, outcomes, duration of follow-up, publication and reporting practice.
MTRC presents a free webinar on its holistic approach to determining evidence requirements for medical technologies, which consists of six steps:
Initial step to understand the current market access situation and the key barriers for the product
Within one country, market access processes may differ depending on the evidence situation for the product, its cost, existing payment mechanism
MTRC employes unique approach, based on the review of the previous reimbursement / HTA decisions to understand the exact evidence requirements for similar types of products
One of the key steps to determine evidence gaps. Based on a focused systematic literature review. Includes in-depth analysis of existing studies
Evidence gap analysis helps to understand, what is missing to support market access activities for the product. Once gaps are understood, a strategy can be put in place to generate additional required evidence
This 9-minute extract presents principle of gathering information about evidence requirements for target processes
This free webinar provides an overview of key trends in market access for medical technologies in Europe, based on extensive consulting practice of MTRC: competition for hospital budget, disinvestment policies, developing therapies vs devices, innovation funding, value-based health care and others.
This free webinar provides overview of typical challenges of market access function (reimbursement, funding, evidence development) and how these challenges can be addressed using MTRC best practices